Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Gulia

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Cancer Reports (Hoboken, N.J.)|July 17, 2020
Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancerThumkur S Shylasree, Abhay K Kattepur, Monisha Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2023
Correlation of Hematological Parameters With Clinical Outcomes in Cervical Cancer Patients Treated With Radical Radio(chemo)therapy: A Retrospective StudyAmrendra Kumar, Lavanya Gurram, Pushpa Naga Ch, et al.
JAMA Oncology|February 10, 2018
Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical TrialShyamkishore Shrivastava, Umesh Mahantshetty, Reena Engineer, et al.
Journal of Contemporary Brachytherapy|February 23, 2023
Clinical outcomes of patients treated with template-based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysisGargee Mulye, Lavanya Gurram, Supriya Chopra, et al.
Indian Journal of Cancer|August 28, 2018
Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapyAmita Maheshwari, Neha Kumar, Sudeep Gupta, et al.
JCO Global Oncology|March 24, 2022
Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in IndiaLavanya Gurram, Samarpita Mohanty, Supriya Chopra, et al.
Cureus|January 27, 2025
Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert ConsensusAshok K Vaid, Olivia Pagani, Anita Ramesh, et al.
Brachytherapy|December 30, 2022
Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemicSupriya Chopra, Jaahid Mulani, Prachi Mittal, et al.
The Lancet. Oncology|January 15, 2024
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trialJyoti Bajpai, Venkatesh Kapu, Sushmita Rath, et al.
Indian Journal of Cancer|August 28, 2018
Locally advanced cervical cancer: A study of 5-year outcomesSupriya Chopra, Meetakshi Gupta, Ashwathy Mathew, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cancer Reports (Hoboken, N.J.)|July 17, 2020
Compliance to treatment guidelines and survival in women undergoing interval debulking surgery for advanced epithelial ovarian cancerThumkur S Shylasree, Abhay K Kattepur, Monisha Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2023
Correlation of Hematological Parameters With Clinical Outcomes in Cervical Cancer Patients Treated With Radical Radio(chemo)therapy: A Retrospective StudyAmrendra Kumar, Lavanya Gurram, Pushpa Naga Ch, et al.
JAMA Oncology|February 10, 2018
Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical TrialShyamkishore Shrivastava, Umesh Mahantshetty, Reena Engineer, et al.
Journal of Contemporary Brachytherapy|February 23, 2023
Clinical outcomes of patients treated with template-based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysisGargee Mulye, Lavanya Gurram, Supriya Chopra, et al.
Indian Journal of Cancer|August 28, 2018
Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapyAmita Maheshwari, Neha Kumar, Sudeep Gupta, et al.
JCO Global Oncology|March 24, 2022
Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in IndiaLavanya Gurram, Samarpita Mohanty, Supriya Chopra, et al.
Cureus|January 27, 2025
Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert ConsensusAshok K Vaid, Olivia Pagani, Anita Ramesh, et al.
Brachytherapy|December 30, 2022
Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemicSupriya Chopra, Jaahid Mulani, Prachi Mittal, et al.
The Lancet. Oncology|January 15, 2024
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trialJyoti Bajpai, Venkatesh Kapu, Sushmita Rath, et al.
Indian Journal of Cancer|August 28, 2018
Locally advanced cervical cancer: A study of 5-year outcomesSupriya Chopra, Meetakshi Gupta, Ashwathy Mathew, et al.
Pageof 7